PYNOD, a novel Apaf-1/CED4-like protein is an inhibitor of ASC and caspase-1
スポンサーリンク
概要
- 論文の詳細を見る
- 2004-06-01
著者
-
Imamura R
Division Of Immunology And Molecular Biology Cancer Research Institute Kanazawa University
-
Imamura Ryu
Center For The Development Of Molecular Target Drugs Cancer Research Institute
-
SUDA Takashi
Center for the Development of Molecular Target Drugs, Cancer Research Institute
-
Suda Takashi
Division Of Immunology And Molecular Biology Cancer Research Institute Kanazawa University
-
WANG Yetao
Center for the Development of Molecular Target Drugs, Cancer Research Institute, Kanazawa University
-
HASEGAWA Mizuho
Center for the Development of Molecular Target Drugs, Cancer Research Institute, Kanazawa University
-
KINOSHITA Takeshi
Center for the Development of Molecular Target Drugs, Cancer Research Institute, Kanazawa University
-
KONDO Chiaki
Center for the Development of Molecular Target Drugs, Cancer Research Institute, Kanazawa University
-
KONAKA Kenji
Center for the Development of Molecular Target Drugs, Cancer Research Institute, Kanazawa University
-
Hasegawa Minoru
Division Of Immunology And Molecular Biology Cancer Research Institute Kanazawa University
-
Wang Yetao
Center For The Development Of Molecular Target Drugs Cancer Research Institute Kanazawa University
-
Konaka Kenji
Center For The Development Of Molecular Target Drugs Cancer Research Institute Kanazawa University
-
Kondo Chiaki
Division Of Immunology And Molecular Biology Cancer Research Institute Kanazawa University
-
Suda Takashi
Center For The Development Of Molecular Target Drugs Cancer Research Institute
-
Kinoshita Takeshi
Division Of Immunology And Molecular Biology Cancer Research Institute Kanazawa University
関連論文
- Mouse CD20 expression and function
- Involvement of IL-17 in Fas ligand-induced inflammation
- PYNOD, a novel Apaf-1/CED4-like protein is an inhibitor of ASC and caspase-1
- Fas-associated factor 1 is a negative regulator of PYRIN-containing Apaf-1-like protein 1
- Frozen-Section Diagnosis of Small Adenocarcinoma of the Lung for Intentional Limited Surgery
- Activation of ASC induces apoptosis or necrosis, depending on the cell type, and causes tumor eradication